
Satsuma Pharmaceuticals STSA
Satsuma Pharmaceuticals EBITDA per Share | STSA
EBITDA per Share Jährlich Satsuma Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.2 | -1.74 | -2.76 | -1.9 | -2.17 | -8.84 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.74 | -8.84 | -3.27 |
EBITDA per Share Vierteljährlich Satsuma Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.32 | - | -0.48 | -0.52 | -0.49 | - | -0.41 | -0.37 | -0.47 | -0.72 | -0.69 | -0.66 | -0.7 | -0.65 | -2.29 | -5.53 | -2.39 | -2.11 | -1.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.32 | -5.53 | -1.19 |
EBITDA per Share anderer Aktien in der Pharmaeinzelhändler
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Annexon
ANNX
|
-1.38 | $ 3.11 | -8.94 % | $ 482 M | ||
|
Acasti Pharma
ACST
|
-0.67 | - | 4.01 % | $ 150 M | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
Galapagos NV
GLPG
|
5.33 | - | - | $ 1.83 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-0.07 | - | -4.36 % | $ 27 M | ||
|
Avenue Therapeutics
ATXI
|
-0.98 | - | -52.27 % | $ 4.45 M | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
0.09 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Achieve Life Sciences
ACHV
|
0.01 | $ 6.78 | 0.89 % | $ 296 M | ||
|
Leap Therapeutics
LPTX
|
-0.62 | - | 368.57 % | $ 41.9 M | ||
|
Lumos Pharma
LUMO
|
-4.49 | - | - | $ 35.3 M | ||
|
Gamida Cell Ltd.
GMDA
|
-1.43 | - | -18.25 % | $ 5.04 M | ||
|
Axcella Health
AXLA
|
-1.41 | - | -16.42 % | $ 249 M | ||
|
Metacrine
MTCR
|
-2.24 | - | - | $ 24.2 M | ||
|
Zealand Pharma A/S
ZEAL
|
-24.4 | - | 0.52 % | $ 821 M | ||
|
Myovant Sciences Ltd.
MYOV
|
-2 | - | -0.04 % | $ 2.62 B | ||
|
Bellerophon Therapeutics
BLPH
|
-2.34 | - | -74.18 % | $ 955 K | ||
|
Idera Pharmaceuticals
IDRA
|
-8.51 | - | -23.04 % | $ 26.6 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Verona Pharma plc
VRNA
|
-0.24 | - | - | $ 69.7 B | ||
|
Atreca
BCEL
|
0.14 | - | -11.76 % | $ 5.79 M | ||
|
Guardion Health Sciences
GHSI
|
-3.4 | - | -0.31 % | $ 3.64 M | ||
|
Opiant Pharmaceuticals
OPNT
|
1.18 | - | - | $ 109 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
ImmunoGen
IMGN
|
-0.86 | - | - | $ 7.92 B | ||
|
Vascular Biogenics Ltd.
VBLT
|
-4.36 | - | -8.77 % | $ 12.4 M | ||
|
Cidara Therapeutics
CDTX
|
-27.7 | - | - | $ 1.41 B | ||
|
Iterum Therapeutics
ITRM
|
-0.95 | - | - | $ 591 K | ||
|
Virpax Pharmaceuticals
VRPX
|
-2.84 | - | -45.12 % | $ 2.85 M | ||
|
Navidea Biopharmaceuticals
NAVB
|
-0.45 | - | -2.99 % | $ 2.47 M | ||
|
Stealth BioTherapeutics Corp
MITO
|
-0.07 | - | - | $ 23.9 M | ||
|
OncoSec Medical Incorporated
ONCS
|
-0.94 | - | 31.87 % | $ 1.61 M | ||
|
BioDelivery Sciences International
BDSI
|
0.38 | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | ||
|
bluebird bio
BLUE
|
-21.7 | - | - | $ 546 M | ||
|
Landos Biopharma
LABP
|
-3.62 | - | 0.58 % | $ 144 M | ||
|
CASI Pharmaceuticals
CASI
|
-2.41 | - | - | $ 35.4 M | ||
|
ContraFect Corporation
CFRX
|
-124 | - | -5.16 % | $ 5.39 M | ||
|
Sigilon Therapeutics
SGTX
|
-1.31 | - | - | $ 728 M | ||
|
Regulus Therapeutics
RGLS
|
-0.88 | - | - | $ 155 M | ||
|
NGM Biopharmaceuticals
NGM
|
-1.81 | - | - | $ 127 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-2.84 | - | - | $ 231 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
-5.45 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | ||
|
Gilead Sciences
GILD
|
8.35 | $ 166.01 | -0.31 % | $ 207 B | ||
|
Assembly Biosciences
ASMB
|
-1.07 | $ 22.14 | -1.6 % | $ 248 M | ||
|
Dynavax Technologies Corporation
DVAX
|
-0.25 | - | - | $ 2.02 B | ||
|
Turning Point Therapeutics
TPTX
|
-4.81 | - | -0.13 % | $ 3.73 B | ||
|
Orgenesis
ORGS
|
-8.95 | - | -33.86 % | $ 61.2 M | ||
|
TCR2 Therapeutics
TCRR
|
-3.89 | - | - | $ 58.1 M |